Published in Neth Heart J on March 01, 2009
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med (2002) 27.55
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med (2005) 27.36
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med (1996) 15.04
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (1999) 10.17
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med (1997) 10.02
Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol (2002) 5.74
Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J (2000) 4.99
Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation (2000) 4.12
Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J (1989) 3.06
Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography. Eur Heart J (2004) 2.68
Assessment of ventricular function and mass by cardiac magnetic resonance imaging. Eur Radiol (2004) 1.70
Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions. Am J Cardiol (1996) 1.69
Multi-detector row CT of left ventricular function with dedicated analysis software versus MR imaging: initial experience. Radiology (2003) 1.32
Accurate estimation of global and regional cardiac function by retrospectively gated multidetector row computed tomography: comparison with cine magnetic resonance imaging. Eur Radiol (2006) 1.17
Implantable defibrillators and sudden cardiac death. Circulation (2004) 1.14
Left ventricular and left atrial dimensions and volumes: comparison between dual-source CT and echocardiography. Invest Radiol (2008) 0.97
Assessment of ventricular function with cardiovascular magnetic resonance. Cardiol Clin (2007) 0.83
Different imaging approaches in the assessment of left ventricular dysfunction: all things equal? Eur Heart J (2000) 0.78
Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry. Circulation (2010) 2.53
Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy. Neurology (2008) 2.21
Is T-wave alternans testing feasible in candidates for prophylactic implantable defibrillators? Neth Heart J (2011) 1.89
Magnetic navigation in AV nodal re-entrant tachycardia study: early results of ablation with one- and three-magnet catheters. Europace (2006) 1.80
Bibliometric data in clinical cardiology revisited. The case of 37 Dutch professors. Neth Heart J (2011) 1.79
Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet (2005) 1.78
Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties. Acta Physiol Scand (2005) 1.67
[Initial diagnostic strategy in the case of transient losses of consciousness: the importance of the medical history]. Ned Tijdschr Geneeskd (2003) 1.55
Genetic knowledge and counselling skills of Dutch cardiologists: sufficient for the genomics era? Eur Heart J (2003) 1.52
[Genetic identification of patients and families with a long-QT syndrome: large regional differences in the result of 10 years]. Ned Tijdschr Geneeskd (2007) 1.46
[Implantable cardioverter-defibrillator in the treatment of two patients with an increased risk of sudden cardiac death]. Ned Tijdschr Geneeskd (2004) 1.40
The works of Dirk Durrer (1918-1984). Neth Heart J (2012) 1.39
[Medication for ADHD and the risk of cardiovascular mortality]. Ned Tijdschr Geneeskd (2006) 1.39
The Hirsch-index: a simple, new tool for the assessment of scientific output of individual scientists: The case of Dutch professors in clinical cardiology. Neth Heart J (2009) 1.30
CRAVT: a prospective, randomized study comparing transvenous cryothermal and radiofrequency ablation in atrioventricular nodal re-entrant tachycardia. Eur Heart J (2004) 1.21
The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome. J Med Genet (2003) 1.13
The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium. Basic Res Cardiol (2009) 1.11
Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology (2009) 1.00
Family and population strategies for screening and counselling of inherited cardiac arrhythmias. Ann Med (2004) 0.98
Fever-triggered ventricular arrhythmias in Brugada syndrome and type 2 long-QT syndrome. Neth Heart J (2010) 0.94
First experience with the wearable cardioverter defibrillator in the Netherlands. Neth Heart J (2012) 0.94
Recurrent and founder mutations in the Netherlands-Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy. Neth Heart J (2013) 0.94
Left cardiac sympathetic denervation in the Netherlands for the treatment of inherited arrhythmia syndromes. Neth Heart J (2014) 0.93
Myocardial viability: impact on left ventricular dilatation after acute myocardial infarction. Heart (2002) 0.93
Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands. Neth Heart J (2010) 0.92
Recurrent and founder mutations in the Netherlands : Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Neth Heart J (2010) 0.91
The sense and nonsense of direct-to-consumer genetic testing for cardiovascular disease. Neth Heart J (2011) 0.91
Rationale and design of the CAREFUL study : The yield of CARdiogenetic scrEening in First degree relatives of sudden cardiac and UnexpLained death victims <45 years. Neth Heart J (2010) 0.90
Cardiac abnormalities in a follow-up study on carriers of Duchenne and Becker muscular dystrophy. Neurology (2011) 0.90
Early prediction of improvement in ejection fraction after acute myocardial infarction using low dose dobutamine echocardiography. Heart (2002) 0.89
Incidence and predictors of phantom shocks in implantable cardioverter defibrillator recipients. Neth Heart J (2013) 0.89
Acute success and short-term follow-up of catheter ablation of isthmus-dependent atrial flutter; a comparison of 8 mm tip radiofrequency and cryothermy catheters. J Interv Card Electrophysiol (2008) 0.89
Can parents adjust to the idea that their child is at risk for a sudden death?: Psychological impact of risk for long QT syndrome. Am J Med Genet A (2005) 0.88
Ten year follow-up after radiofrequency catheter ablation for atrioventricular nodal reentrant tachycardia in the early days forever cured, or a source for new arrhythmias? Pacing Clin Electrophysiol (2005) 0.88
High distress in parents whose children undergo predictive testing for long QT syndrome. Community Genet (2005) 0.87
Prognostic value of microvolt T-wave alternans in a real-world ICD population. Twente ICD Cohort Studie (TICS). Neth Heart J (2014) 0.87
Optimisation of cardiac resynchronization therapy in clinical practice during exercise. Neth Heart J (2013) 0.86
Preferences of cardiologists and clinical geneticists for the future organization of genetic care in hypertrophic cardiomyopathy: a survey. Clin Genet (2005) 0.85
Coronary artery-bronchial artery fistulas: report of two Dutch cases with a review of the literature. Neth Heart J (2014) 0.85
Clinical implementation of guidelines for cardioverter defibrillator implantation: lost in translation? Neth Heart J (2007) 0.84
Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers. Neth Heart J (2009) 0.84
Pregnancy and the risk of torsades de pointes in congenital long-QT syndrome. Neth Heart J (2008) 0.83
Infarct tissue characteristics of patients with versus without early revascularization for acute myocardial infarction: a contrast-enhancement cardiovascular magnetic resonance imaging study. Heart Vessels (2011) 0.82
Continuation of vitamin K antagonists as acceptable anticoagulation regimen in patients undergoing pulmonary vein isolation. Neth Heart J (2012) 0.81
Structural abnormalities of the left ventricle in hypertrophic cardiomyopathy mutation carriers detectable before the development of hypertrophy. Neth Heart J (2007) 0.81
Netherlands Heart Journal: accepted into PubMed Central! Neth Heart J (2006) 0.81
GENCOR: a national registry for patients and families suffering from a familial heart disease in the Netherlands. Neth Heart J (2006) 0.81
Noninvasive detection of epicardial and endocardial activity of the heart. Neth Heart J (2011) 0.81
Peak longitudinal strain delay is superior to TDI in the selection of patients for resynchronisation therapy. Neth Heart J (2010) 0.81
Recurrent and Founder Mutations in the Netherlands: the Long-QT Syndrome. Neth Heart J (2010) 0.80
[Not Available]. Neth Heart J (2011) 0.80
Letter regarding article by McNair et al, "SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia". Circulation (2005) 0.80
Recurrent and founder mutations in inherited cardiac diseases in the Netherlands. Neth Heart J (2009) 0.80
Founder mutations in the Netherlands: familial idiopathic ventricular fibrillation and DPP6. Neth Heart J (2011) 0.80
Percutaneous pulmonary valve replacement: a new development in the lifetime strategy for patients with congenital heart disease. Neth Heart J (2007) 0.79
Obstructive intramyocardial haematoma after percutaneous coronary intervention. Neth Heart J (2012) 0.79
[Hypertrophic cardiomyopathy: a genetically-carried heart disease]. Ned Tijdschr Geneeskd (2002) 0.79
Comparison of radiofrequency versus cryothermy catheter ablation of septal accessory pathways. Heart (2003) 0.79
Arrhythmogenic right ventricular dysplasia as a possible cause of sudden cardiac death: a case report and clinical review. Neth Heart J (2004) 0.78
Left ventricular lead placement within a coronary sinus side branch, using only a floppy guide wire and magnetic navigation. Heart (2005) 0.78
Arrhythmogenic right ventricular cardiomyopathy: asymptomatic to life threatening as illustrated by the cases of two sisters. Neth Heart J (2007) 0.77
T-wave alternans in a patient with long-QT syndrome type 3. Neth Heart J (2006) 0.77
A large family characterised by nocturnal sudden death. Neth Heart J (2002) 0.77
Flush after syncope: not always an arrhythmia. J Cardiovasc Electrophysiol (2006) 0.77
De novo mutation in the KCNQ1 gene causal to Jervell and Lange-Nielsen syndrome. Clin Genet (2013) 0.76
Genetic predisposition for sudden cardiac death in myocardial ischaemia: the Arrhythmia Genetics in the NEtherlandS study. Neth Heart J (2011) 0.76
Primary prevention: prime time?: ICD trials (and tribulations). Neth Heart J (2004) 0.75
TDI-echocardiography: a new screening tool for long QT syndrome? Eur J Echocardiogr (2003) 0.75
Coexistence of a bradycardia- and tachycardia-dependent bundle branch block. Neth Heart J (2004) 0.75
Palpitations and dizziness in a 65-year-old man. Neth Heart J (2006) 0.75
Left atrial myxoma as a cause of stroke. Neth Heart J (2006) 0.75
One more time: bibliometric analysis of scientific output remains complicated. Neth Heart J (2011) 0.75
Cardiogenetic counselling in a non-university hospital. Neth Heart J (2007) 0.75
Electrical isolation of pulmonary veins using cryothermal energy: study design and initial results. Neth Heart J (2003) 0.75
Rationale of the SEAS study: Serial Echocardiography After Subarachnoid haemorrhage, a prospective national, multicentre, multidisciplinary, cohort study to evaluate cardiac abnormalities following intracranial haemorrhage. Neth Heart J (2006) 0.75
An extended family suddenly confronted with a life-threatening hereditary arrhythmia. Neth Heart J (2005) 0.75
Right you are. Neth Heart J (2005) 0.75
Recent breakthroughs in the genetics of atrial fibrillation. Neth Heart J (2003) 0.75
Electrical isolation of pulmonary veins using cryothermal energy: study design and initial results. Neth Heart J (2003) 0.75
The ECG of a (cardio)myopathy? Neth Heart J (2005) 0.75
'Brugada ECG' elicited by imipramine overdose. Neth Heart J (2004) 0.75
Should I be worried? Neth Heart J (2006) 0.75
ECG screening of newborns to avoid sudden infant death syndrome? Neth Heart J (2006) 0.75
Recommendations and cardiological evaluation of athletes with arrhythmias: Part 2. Neth Heart J (2004) 0.75
A usual presentation of an unusual diagnosis. Neth Heart J (2002) 0.75
Recommendations and cardiological evaluation of athletes with arrhythmias: Part 1. Neth Heart J (2004) 0.75
Feasibility of TWA testing - reply. Neth Heart J (2012) 0.75
It's not what you think it is. Neth Heart J (2005) 0.75
Primary ventricular fibrillation in acute myocardial infarction: an inherited disease? Neth Heart J (2001) 0.75
First Dutch experience with percutaneous left atrial appendage transcatheter occlusion. Neth Heart J (2003) 0.75
Familial primary arrhythmia syndromes: Nice to know or need to know. Neth Heart J (2002) 0.75
Nightly phenomena, day time work? Neth Heart J (2004) 0.75
Not just any ICD device in patients with long-QT syndrome. Neth Heart J (2007) 0.75
Brugada syndrome. Eur Heart J (2002) 0.75
A fainting lady with some extrasystoles. Neth Heart J (2004) 0.75
COMPANION - a friend indeed. Neth Heart J (2003) 0.75